We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

A scientist pipetting into an assay plate.

AI Method Accelerates Drug Discovery for Parkinson’s 10-Fold, Study Finds

A purple human brain.

Antipsychotic Use in Dementia Linked to Elevated Health Risks

Umbrella-shaped antibacterial toxin particles drifting toward and engaging a bacterial target cell.

Soil Bacteria Produce Unique Antimicrobial Particles

Study Investigates Links Between HIV Drugs and Reduced Alzheimer’s Disease Incidence

Scientists Pinpoint Brain Region Crucial for Attention Control

Targeted Liver Cancer Treatment May Help Cut Side Effects

News

AstraZeneca Returns Worldwide Rights to IPI-504 and IPI-493 Development Programs to Infinity Pharmaceuticals

The rights will enable the development and commercialization of Infinity’s heat shock protein 90 drug candidates IPI-504 and IPI-493 for cancer treatment.

Bristol-Myers Squibb and Exelixis Enter Global Collaboration on Two Cancer Programs

Programs include XL184, a Phase III inhibitor of MET, VEGFR2 and RET, and XL281, a Phase I Inhibitor of RAF Kinase.

New Data Show Zometa® Enhances Impact of Chemotherapy on Reducing Breast Tumor Size

Adding Zometa to chemotherapy prior to surgery led to an additional 33% reduction in tumor size, resulting in fewer mastectomies.

Oncolytics Biotech REOLYSIN® Exceeds Primary Statistical Endpoint in U.S. Phase 2 Sarcoma Study

The Phase 2 clinical trial has evaluated the intravenous administration of REOLYSIN® in patients with various sarcomas that have metastasized to the lung.

Helsinn Healthcare and Zealand Pharma Sign a Partnering Agreement for Zp1846

Helsinn receives license to ZP1846 for further development, regulatory approvals, manufacturing, marketing and sales of the compound.

VIVUS Initiates Avanafil Phase 3 Trials in Males with ED

The REVIVE study is a randomized, double-blind, placebo-controlled, efficacy and safety study of avanafil in men with a history of ED.

MorphoSys Announces Second Clinical Milestone in Therapeutic Antibody Program

MorphoSys and Centocor have enrolled a patient in a Phase 2 clinical trial with a HuCAL-derived fully human antibody.

Australian Cancer Research Organization CTx Choose IDBS to Protect Patent Data

CTx has selected both E-WorkBook and ActivityBase to manage its drug discovery and development on a global multi-site basis.

pSivida new Clinical Trial for Drug Delivery Device in AMD

The Company begins clinical trial using its Medidur™ technology to assess the safety and efficacy of Iluvien in patients with bilateral geographic atrophy.

AFFiRiS Begins Development of a Parkinson's Vaccine

AFFiRiS starts pre-clinical development of its first Parkinson's vaccine that will be investigated for efficacy in Parkinson models.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter